Free Trial

Autonomix Medical (AMIX) Competitors

Autonomix Medical logo
$1.26 -0.05 (-3.82%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$1.29 +0.03 (+2.38%)
As of 08/6/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AMIX vs. BDMD, XAIR, MHUA, DHAI, INBS, PTHL, PAVM, LYRA, LUCY, and BTCY

Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Baird Medical Investment (BDMD), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), DIH Holding US (DHAI), Intelligent Bio Solutions (INBS), Pheton (PTHL), PAVmed (PAVM), Lyra Therapeutics (LYRA), Innovative Eyewear (LUCY), and Biotricity (BTCY). These companies are all part of the "medical equipment" industry.

Autonomix Medical vs. Its Competitors

Baird Medical Investment (NASDAQ:BDMD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical InvestmentN/AN/AN/AN/AN/A
Autonomix MedicalN/AN/A-$11.41M-$7.47-0.17

Baird Medical Investment has a beta of -1, meaning that its stock price is 200% less volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -2.96, meaning that its stock price is 396% less volatile than the S&P 500.

Autonomix Medical has a consensus price target of $16.50, indicating a potential upside of 1,209.52%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Autonomix Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 32.4% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Baird Medical Investment's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Autonomix Medical N/A -174.70%-133.35%

In the previous week, Autonomix Medical's average media sentiment score of 1.00 beat Baird Medical Investment's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Baird Medical Investment Neutral
Autonomix Medical Positive

Summary

Baird Medical Investment beats Autonomix Medical on 5 of the 9 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMIX vs. The Competition

MetricAutonomix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$6.39M$6.94B$5.57B$9.47B
Dividend YieldN/A1.34%4.31%4.13%
P/E Ratio-0.1720.6229.3723.99
Price / SalesN/A61.26444.2496.60
Price / CashN/A20.8935.8458.51
Price / Book0.385.558.085.58
Net Income-$11.41M$178.18M$3.26B$265.35M
7 Day Performance-12.50%-0.39%0.46%-0.07%
1 Month Performance-10.64%-2.58%4.84%1.76%
1 Year Performance-90.41%11.78%30.29%25.39%

Autonomix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMIX
Autonomix Medical
3.3511 of 5 stars
$1.26
-3.8%
$16.50
+1,209.5%
-91.2%$6.39MN/A-0.171Positive News
Gap Down
BDMD
Baird Medical Investment
N/A$2.04
-2.9%
N/AN/A$13.42MN/A0.00N/AGap Down
XAIR
Beyond Air
4.0101 of 5 stars
$2.96
-7.5%
$23.67
+699.5%
-72.3%$12.79M$3.70M-0.1970Upcoming Earnings
Short Interest ↑
MHUA
Meihua International Medical Technologies
0.8592 of 5 stars
$0.40
+1.9%
N/A-43.3%$12.73M$96.90M0.00620
DHAI
DIH Holding US
0.8107 of 5 stars
$0.25
-8.4%
N/A-89.3%$11.70M$64.47M-0.82N/A
INBS
Intelligent Bio Solutions
0.4215 of 5 stars
$1.59
+3.9%
N/A+28.9%$10.99M$3.11M0.0010Gap Up
PTHL
Pheton
N/A$1.65
-94.7%
N/AN/A$10.86M$448.20K0.0011Positive News
High Trading Volume
PAVM
PAVmed
4.4511 of 5 stars
$0.58
+1.1%
$19.00
+3,191.2%
-40.9%$9.87M$2.99M0.8190News Coverage
Positive News
Upcoming Earnings
LYRA
Lyra Therapeutics
3.4524 of 5 stars
$7.26
-6.9%
$100.00
+1,277.4%
-58.9%$9.62M$1.19M-0.1250Upcoming Earnings
LUCY
Innovative Eyewear
0.0703 of 5 stars
$2.10
flat
N/A-46.3%$9.60M$1.64M-0.539Positive News
Upcoming Earnings
BTCY
Biotricity
N/A$0.38
-6.3%
N/A-2.2%$9.34M$12.06M-0.3540

Related Companies and Tools


This page (NASDAQ:AMIX) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners